CMMB Financials

Chemomab Therapeutics Ltd DRC - Financial statements & key metrics

Stock Price

$2.83

Market Cap

$22.16M

P/E Ratio

23.3

EPS

$-1.44

Income Statement Highlights

Most Recent Quarter: 2022-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-27.65M

EPS (Diluted)

$0.12

Balance Sheet Highlights

Total Assets

$43.06M

Total Liabilities

$6.84M

Shareholders Equity

Cash & Equivalents

$13.52M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-20.37M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-73.2%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is CMMB revenue?

View CMMB's income statement for detailed revenue data.

Is CMMB profitable?

CMMB reported a loss of $27.65M in the most recent quarter.

What is CMMB market cap?

CMMB has a market capitalization of $22.16M, making it a small-cap stock.

Does CMMB have debt?

View CMMB's balance sheet for debt information.

What is CMMB cash flow?

Cash flow data is available in the full financial statements.